We are live on ! Find out more
NVRO

NEVRO CORP.

Delisted

NVRO was delisted on the 2nd of April, 2025.

209 hedge funds and large institutions have $2.95B invested in NEVRO CORP. in 2021 Q4 according to their latest regulatory filings, with 43 funds opening new positions, 79 increasing their positions, 58 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

72% more first-time investments, than exits

New positions opened: 43 | Existing positions closed: 25

36% more repeat investments, than reductions

Existing positions increased: 79 | Existing positions reduced: 58

8% more funds holding

Funds holding: 194209 (+15)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

27% less call options, than puts

Call options by funds: $25.2M | Put options by funds: $34.3M

32% less capital invested

Capital invested by funds: $4.37B → $2.95B (-$1.41B)

Holders
209
Holders Change
+15
Holders Change %
+7.73%
% of All Funds
3.22%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
43
Increased
79
Reduced
58
Closed
25
Calls
$25.2M
Puts
$34.3M
Net Calls
-$9.13M
Net Calls Change
-$4.33M
Name Holding Trade Value Shares
Change
Change in
Stake
Prudential Financial
101
Prudential Financial
New Jersey
$1.75M -$47K -469 -2%
TRSOTSOK
102
Teachers Retirement System of the State of Kentucky
Kentucky
$1.5M +$1.85M +18,482 New
AIG
103
American International Group
New York
$1.49M -$55.1K -550 -3%
Macquarie Group
104
Macquarie Group
Australia
$1.47M -$1.66M -16,542 -48%
Jane Street
105
Jane Street
New York
$1.43M -$5.67M -56,631 -76%
PP
106
Paloma Partners
Connecticut
$1.32M +$751K +7,495 +86%
Bank of Montreal
107
Bank of Montreal
Ontario, Canada
$1.25M -$462K -4,613 -24%
HighTower Advisors
108
HighTower Advisors
Illinois
$1.24M +$487K +4,859 +47%
HF
109
HRT Financial
New York
$1.18M +$1.2M +12,002 +471%
State Board of Administration of Florida Retirement System
110
State Board of Administration of Florida Retirement System
Florida
$1.14M
Tudor Investment Corp
111
Tudor Investment Corp
Connecticut
$1.12M +$1.39M +13,847 New
VOYA Investment Management
112
VOYA Investment Management
Georgia
$1.09M -$12.1K -121 -0.9%
Walleye Capital
113
Walleye Capital
New York
$1.02M +$880K +8,781 +229%
Toronto Dominion Bank
114
Toronto Dominion Bank
Ontario, Canada
$991K +$1.22M +12,218 New
MIM
115
MetLife Investment Management
New Jersey
$981K
OAM
116
Oppenheimer Asset Management
New York
$901K -$416K -4,154 -27%
ECM
117
ExodusPoint Capital Management
New York
$900K +$904K +9,020 +432%
Citigroup
118
Citigroup
New York
$783K +$512K +5,108 +112%
QT
119
Quantbot Technologies
New York
$765K +$946K +9,437 New
DA
120
Duality Advisers
Florida
$761K -$552K -5,511 -37%
ACM
121
AlphaCrest Capital Management
New York
$743K +$510K +5,092 +125%
MLICM
122
Metropolitan Life Insurance Company (MetLife)
New York
$740K
MF
123
Magnetar Financial
Illinois
$727K +$898K +8,962 New
ASRS
124
Arizona State Retirement System
Arizona
$723K -$8.42K -84 -0.9%
TI
125
Trexquant Investment
Connecticut
$721K +$892K +8,899 New

NVRO Hedge Fund Activity: Q4 2021 in Review

209 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in NEVRO CORP. (NVRO) for Q4 2021, worth a combined $2.95B — down 32% from $4.37B a quarter earlier.

Buyers outnumbered sellers: 43 funds opened new NVRO positions and 25 closed out — a net gain of 18 holders — while 79 added to existing stakes and 58 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $84.5M. The largest seller was T. Rowe Price Associates, cutting an estimated $235M.

  • 209 institutional investors held NEVRO CORP. (NVRO) as of Q4 2021, up from 194 in Q3 2021.
  • Funds reported $2.95B of NEVRO CORP. stock for Q4 2021, down 32% quarter-over-quarter.
  • 43 funds opened new NEVRO CORP. positions in Q4 2021 and 25 closed out, a net change of +18 holders.
  • The largest NEVRO CORP. buyer in Q4 2021 was Wellington Management Group, an estimated $84.5M added.
  • The largest NEVRO CORP. seller in Q4 2021 was T. Rowe Price Associates, an estimated $235M sold.

Based on aggregated 13F filings for Q4 2021.